ERAP2

1. ERAP2 predicts clinical pregnancy in humans (AUROC = 0.768, 95% CI 0.749-0.787).

   “and clinical pregnancy (AUROC = 0.768, 95% CI 0.749-0.787).”

   Humansin POI patientsserum4 yearsfemales

   ERAP2 as a Potential Marker for Ovarian Ageing and Spontaneous Ovulation Recovery in Women With Premature Ovarian Insufficiency

   BJOG : an international journal of obstetrics and gynaecology·4 Dec 2025

1. ERAP2 predicts intermittent recovery of ovarian function in humans (AUROC = 0.763, 95% CI 0.734-0.792).

   “ERAP2 was found to be a new biomarker for predicting intermittent recovery of ovarian function (AUROC = 0.763, 95% CI 0.734-0.792)”

   Humansin POI patientsserum4 yearsfemales

   ERAP2 as a Potential Marker for Ovarian Ageing and Spontaneous Ovulation Recovery in Women With Premature Ovarian Insufficiency

   BJOG : an international journal of obstetrics and gynaecology·4 Dec 2025

1. ERAP2 is associated with premature ovarian insufficiency in humans (5.78 ± 2.29 ng/mL vs. 4.81 ± 2.20 ng/mL, p = 0.018).

   “POI patients exhibited significantly elevated serum ERAP2 levels compared to controls (5.78 ± 2.29 ng/mL vs. 4.81 ± 2.20 ng/mL, p = 0.018).”

   Humanscompared to controlsserumfemales

   ERAP2 as a Potential Marker for Ovarian Ageing and Spontaneous Ovulation Recovery in Women With Premature Ovarian Insufficiency

   BJOG : an international journal of obstetrics and gynaecology·4 Dec 2025

More on Premature ovarian insufficiency